Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes.
about
RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrestPAK signalling during the development and progression of cancerCopy number variability in Parkinson's disease: assembling the puzzle through a systems biology approachPanCGH: a genotype-calling algorithm for pangenome CGH data.Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomasAnaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome.Ladder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63Diagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification.Genetic and epigenetic alterations during renal carcinogenesis.Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterationsArray comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinomaThe protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.Computational methods for the analysis of array comparative genomic hybridization.Recent advances in array comparative genomic hybridization technologies and their applications in human genetics.Epigenetic instability and chromosomal instability in hepatocellular carcinoma.Techniques used in studies of age-related DNA methylation changes.Molecular biomarkers for cancer detection in blood and bodily fluids.Whole genome scanning as a cytogenetic tool in hematologic malignancies.High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromesCytogenetic analysis of spontaneously discharged products of conception by array-based comparative genomic hybridization.Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcomeExternal quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity.Medical treatments: in association or alone, their role and their future perspectives: novel molecular-targeted therapy for hepatocellular carcinoma.Genetics of medulloblastoma: clues for novel therapies.DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells.A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity.A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson's diseaseNovel intragenic duplications and mutations of CASK in patients with mental retardation and microcephaly with pontine and cerebellar hypoplasia (MICPCH).Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas.
P2860
Q24322861-1FB0C0A2-E5AA-4488-AC9D-A30ED87B498BQ28307460-33725CD6-974D-43AF-BCA4-0CDB9342E2C3Q33364337-FCD042AF-9E19-47DA-BE20-B9B7E075512AQ33398277-741A366F-7139-4C09-B32D-C91854954641Q33507269-68578863-1E22-4877-BB16-592C195B4832Q33691759-DBA9281C-7E3D-4C72-B788-08ACF40F8069Q33942262-258711D6-F176-49E9-BD5D-324570898862Q34344422-FDE0C74C-7CF1-4854-B452-CF0E930B4BFAQ34442914-1D6F0C9F-22EE-40D1-9838-FAC6342CB932Q34467232-EAA1D6CA-BEB3-4F8C-97AA-18057B99766CQ34619796-E2AE40E2-4DC7-495C-8063-0BD1947AD2EAQ34734078-3947357D-F160-4DC4-98DA-159BE0BD0F6BQ34978321-7A7FE538-3BDD-4B6F-9746-C90D5F6F1EE8Q35051418-81B94995-7A89-4F66-95DB-4995E6142110Q35179061-396F4CC4-99FB-4D01-8AD1-6039F97E6A5EQ36122880-E50C9937-57F9-4FE9-8CC5-E4ADF84B66A9Q36313208-418DDCE4-FC7A-4F52-A144-05318ADF7CC0Q36411144-380D264A-081A-4FBE-911F-99A452D2BDB0Q36521045-72FC13BB-8205-4615-83CD-5EE1BB933BF4Q36627755-889C4A1D-E9C0-4A7C-95A1-43B47F30A2AEQ36835203-C79152A9-D374-42FF-93CB-4867C7F8283CQ37036713-BB44E83B-AFD2-4C08-9259-BDC89870BCD9Q37037506-09646847-FD7C-4097-B724-792DDDBC7021Q37090440-089B690B-E4D3-401A-B115-C1FE2209CFBAQ37244115-1F62B566-D007-4B22-B89B-88E8FA10FC37Q37639189-16F3462E-E9D2-44BA-9CEC-9744152C0FC2Q37737307-9631EB67-1195-464A-9A14-B1A00F32905DQ37961740-3CCE4EB8-D413-478C-AB40-4B9CB209C3A7Q39633864-25FC378F-71EF-4846-A94B-B6C47C34345BQ39732683-8E103941-0FDE-43C6-B302-489E1CC948A0Q39855238-177F5274-68BC-4BE6-82FD-EC26574AB541Q39985982-79F85A21-7603-4F7B-855B-09B2A3EEA3A5Q39996404-205FB455-EB0A-4B29-810F-1BD22AFEB29CQ40114074-BF504A49-9BE9-4AA6-9FF3-C4466FFE13A1Q40141213-DD604F93-6BDF-4FBD-AC0A-85CB2339B2EFQ40141225-9576721A-B1E2-42B1-B531-7D022DB6B87FQ40241085-A9E4FF4E-EF51-40E0-8B79-46806071031AQ41482149-D8878B59-20B3-4B88-9750-353F99B72612Q41935209-2BD81DB2-559D-4199-B45D-F21067C5FB80Q42803466-89E1D18F-5632-4D7D-9593-0A107658EE5F
P2860
Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Comparative genomic hybridizat ...... of novel cancer-related genes.
@ast
Comparative genomic hybridizat ...... of novel cancer-related genes.
@en
type
label
Comparative genomic hybridizat ...... of novel cancer-related genes.
@ast
Comparative genomic hybridizat ...... of novel cancer-related genes.
@en
prefLabel
Comparative genomic hybridizat ...... of novel cancer-related genes.
@ast
Comparative genomic hybridizat ...... of novel cancer-related genes.
@en
P2093
P2860
P1433
P1476
Comparative genomic hybridizat ...... of novel cancer-related genes.
@en
P2093
Issei Imoto
Johji Inazawa
P2860
P304
P356
10.1111/J.1349-7006.2004.TB02486.X
P577
2004-07-01T00:00:00Z